Pancreatic Cancer Research

ResearcherAnhui Medical UniversityActive in the last 2 years

Ping Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0958-6784; OpenAlex author ID A5100655593. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Immune-Mitochondrial Crosstalk in Pancreatic Adenocarcinoma: Systematic Identification of Prognostic Biomarkers Through Immune Dictionary Framework Co-author DOI 10.2174/0118715303422686250925054821↗
  2. Elemene Injection Suppresses Pancreatic Cancer Progress through Regulating Cell Adhesion: A Research Based upon Network Pharmacology and Verification Test. Last author DOI 10.2174/0109298673351591241114101143↗
  3. Brucine Inhibits Proliferation of Pancreatic Ductal Adenocarcinoma through PI3K/AKT Pathway-induced Mitochondrial Apoptosis. Last author DOI 10.2174/0115680096274284231116104554↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jiangang Zhao · 2 shared papers, 2025–2026 · strength 0.78
  2. Xinghe Liao · 1 shared paper, 2026 · strength 0.36
  3. Hao Chen · 1 shared paper, 2026 · strength 0.36
  4. Fenglin Zhang · 1 shared paper, 2026 · strength 0.36
  5. You Wu · 1 shared paper, 2024 · strength 0.31
  6. Panling Xu · 1 shared paper, 2024 · strength 0.31

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.